8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 9, 2023 · 3y ago · Accession 0001193125-23-164435
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Fulcrum Therapeutics, Inc.
- Ticker
- FULC
- CIK
- 1680581
- Form type
- 8-K
- Filing date
- Jun 9, 2023
- Report date
- Jun 8, 2023
- Document
- d463131d8k.htm
- Size
- 196 KB